United Therapeutics Corp. (UTHR)
464.93
-7.06
(-1.50%)
USD |
NASDAQ |
Jan 16, 16:00
464.92
-0.01
(-0.00%)
After-Hours: 20:00
United Therapeutics Market Cap: 20.02B for Jan. 16, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Corcept Therapeutics, Inc. | 3.653B |
| Gilead Sciences, Inc. | 154.97B |
| Johnson & Johnson | 526.82B |
| Catalyst Pharmaceuticals, Inc. | 2.790B |
| Plus Therapeutics, Inc. | 39.55M |
Market Cap Related Metrics
| PE Ratio | 17.62 |
| PS Ratio | 7.167 |
| PEG Ratio | 1.110 |
| Price to Book Value | 3.038 |
| Price to Free Cash Flow | 20.08 |
| Price | 464.93 |
| Earnings Yield | 5.68% |
| PEGY Ratio | 1.110 |
| Operating PE Ratio | 14.79 |
| Normalized PE Ratio | 17.42 |